Elation Health

Elation Health Competitive Intelligence & Landscape

elationhealth.com ·

Overview

Elation Health Overview

Elation Health is a leading technology platform dedicated to supporting high-value primary care practices. Founded in 2010, the company offers a clinical-first approach through its collaborative Electronic Health Record (EHR) platform, designed to help practices grow, communicate effectively, and deliver personalized patient care. Elation Health aims to empower primary care clinicians to excel in their practice while navigating the evolving healthcare landscape. The company is headquartered in San Francisco, California, and as of early 2026, it serves over 32,000 clinicians who care for millions of Americans (Elation Health, Elation Health).

The core offerings from Elation Health include an integrated suite of solutions encompassing practice management, electronic health records (EHR), and a patient portal. Notably, Elation Health was the first EHR solution to incorporate AI-first technology directly into its core EHR system, with features like "Note Assist" designed to minimize administrative burdens and enhance practice efficiency (Elation Health, Elation Health). The platform also features robust interoperability with over 300 integrations, allowing for extensive customization and seamless integration with other healthcare systems (Elation Health).

Elation Health primarily serves independent primary care practices of all sizes, from those just starting to established and scaling networks (Elation Health). Their commitment is to primary care clinicians and practices that prioritize exceptional, patient-centered care, enabling them to thrive while maintaining the integrity of medical practice (Elation Health, Elation Health). The company has experienced significant growth, with approximately 176 employees and an annual revenue of $86.0 million as of early 2026 (Elation Health). Elation Health has also been recognized with the Best in KLAS award for Small Practice EHR/PM for two consecutive years, including in 2026 (Elation Health).

Elation Health

Elation Health Weekly Intel Updates

Receive weekly intel updates about Elation Health straight to your inbox.

Competitors

Elation Health Competitors

Elation Health is a prominent player in the primary care-focused EHR market, known for its community-driven approach and tailored solutions for clinicians. It emphasizes patient care monitoring and practice management, competing directly with other specialized EHR providers (Owler). Its key differentiator is its focus on small practices and independent clinicians, offering a user-friendly interface and targeted features that support patient engagement and care coordination.

Epic Systems stands out as a giant in the healthcare IT sector, primarily serving large hospital networks and health systems. It offers a comprehensive, scalable platform with extensive modules for EMR, revenue cycle management, and interoperability, making it ideal for large-scale organizations. Epic’s market position is reinforced by its high customization capabilities and interoperability focus, although its pricing and implementation complexity are higher compared to Elation (marianaai.com).

Athenahealth is known for its cloud-native platform that emphasizes ease of use, affordability, and integrated revenue cycle management. It caters mainly to small and mid-sized practices, offering streamlined workflows and a focus on improving operational efficiency. Compared to Elation, Athenahealth provides broader market coverage and a more extensive network-enabled system, often favored for its simplicity and cost-effectiveness (marianaai.com).

Practice Fusion is an affordable, cloud-based EHR solution targeting small practices and independent clinicians. Its key advantage is its low cost and ease of onboarding, making it accessible for practices with limited budgets. While it may lack some advanced features of larger systems like Epic or Athenahealth, Practice Fusion offers a straightforward, user-friendly experience that appeals to smaller practices seeking basic EHR functionalities (softwarefinder.com).

Welligent is another competitor focusing on behavioral health and specialty practices, providing tailored solutions that emphasize patient engagement and clinical documentation. Its market niche is smaller but highly specialized, contrasting with Elation’s broader primary care focus. Welligent’s differentiation lies in its specialty-specific features and flexible deployment options, making it a strong choice for practices needing specialized EHR capabilities (Owler).

Product & Pricing

Elation Health Product and Pricing Intelligence

Elation Health offers a comprehensive EHR and billing platform tailored specifically for primary care practices. As of 2026, their pricing model is quote-based, meaning potential clients need to contact Elation directly for a customized quote that considers their practice size and needs (EHR Source). Their platform includes AI-powered tools like Note Assist, which helps streamline documentation and reduce administrative burden, and Elation Billing, which automates claims submission and improves reimbursement speed (EHR Source).

Recent updates highlight an integrated approach combining clinical workflows, billing, and patient engagement, emphasizing ease of use and scalability. Elation's platform is recognized for its clinical-first design, with features such as a three-panel view for intuitive charting and patient focus, making it highly suitable for independent primary care practices (Toolradar). Overall, Elation's pricing remains flexible and tailored, with no publicly listed fixed plans or tiers, reflecting their focus on personalized solutions for healthcare providers (EHR Source).

Ad Campaigns

Elation Health Ad Campaigns

Elation Health is currently running 206 ads across Google, LinkedIn — 200 on Google and 6 on LinkedIn. Explore Elation Health's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Elation Health's ads

View ads

Hiring & Layoffs

Elation Health Hiring and Layoffs

As of early 2026, Elation Health continues to demonstrate a strong hiring trend, with recent updates highlighting ongoing recruitment efforts. The company’s careers page lists current openings, emphasizing their commitment to expanding their team to support their mission of transforming primary care through innovative EHR solutions (Elation Health Careers). Notably, the company has been actively adding to its leadership team, including new executive hires such as a Chief Product Officer in late 2023, signaling strategic growth and a focus on innovation (Elation Health adds to leadership team).

While specific layoffs are not reported, the company's sustained growth and recent milestones, including recognition for their platform and AI-driven innovations, suggest a positive outlook on their strategic hiring patterns. Their focus on expanding their clinical-first platform and supporting primary care practices aligns with a strategy aimed at scaling their technological capabilities and market reach (Elation Health 2025 Year-End Highlights). Overall, their hiring patterns reflect a company focused on innovation, leadership expansion, and market growth, rather than downsizing or layoffs.

Leadership

Elation Health Management and Leadership Team

Elation Health is led by a dedicated team focused on advancing high-value primary care through innovative technology. The company was co-founded in 2010 by Kyna Fong, who serves as CEO, and Conan Fong, who holds the position of Chief Experience Officer. Kyna Fong brings a strong background in health policy and computer science, with degrees from Stanford and Harvard, while Conan Fong offers expertise in physician practice workflows and operations, with a background from Johns Hopkins. The leadership team also includes Nikolaus Trotta, who joined as COO and President in late 2024, bringing nearly two decades of experience in healthcare technology and finance, including prior service in the U.S. Army (Elation Health, Elation Health).

In addition to the core leadership, Elation Health has strategically expanded its executive team to support growth. Recent additions include Dr. Sara Pastoor as Head of Primary Care Advancement (Elation Health). Previously, in July 2023, the company announced three new executive hires to bolster its primary care vision: Sarah Kasten as chief people officer, Lennart Lepner as chief financial officer, and Blake Wolff as head of customer (Elation Health). These appointments reflect Elation Health's commitment to scaling its operations and enhancing its platform.

Elation Health, headquartered in San Francisco, California, operates as a privately held, venture capital-backed company founded in 2010 (PitchBook). The company has raised $50 million in funding and employs between 201 and 500 individuals (Prospeo). While specific board members are not detailed in the provided results, the company's leadership structure emphasizes a clinical-first approach, aiming to empower primary care providers and strengthen the physician-patient relationship through its EHR and practice management solutions (Elation Health, PitchBook). The company has also been recognized, with Elation Health winning a Best in KLAS Award for 2026 (Elation Health).

Financials

Elation Health Financial Performance, Fundraising, M&A

Elation Health has demonstrated strong financial growth and active fundraising efforts in recent years. As of 2025, the company has raised a total of $108.5 million in venture funding, with the latest funding round being a Series D of $50 million completed in July 2022 (PitchBook, Clay). This significant capital infusion highlights its robust financial health and investor confidence.

In terms of revenue, Elation Health has achieved substantial operational milestones, including supporting over 20 million in-office and virtual visits through its primary care platform, indicating a strong market presence and revenue-generating capacity (Elation Health 2022 Press Release). The company’s focus on primary care innovation, AI-powered solutions, and expanding platform features has contributed to its growth and market valuation.

Although specific valuation figures are not publicly disclosed, the company's continued fundraising, strategic investments, and expansion into AI-driven healthcare solutions suggest a high valuation and positive outlook for future M&A activity. Elation Health’s recent milestones and funding rounds underscore its position as a key player in the healthtech sector, with ongoing potential for acquisitions and strategic partnerships (Tracxn).

Partnerships

Elation Health Partnerships, Clients and Vendors

Elation Health has established a robust network of partnerships, clients, and vendors to enhance its primary care technology platform. Notable partnerships include collaborations with Surescripts, which supports patient-specific prescription cost transparency and medication coverage data at the point of care, and Zocdoc, enabling seamless online scheduling and reducing administrative burdens for primary care providers (elationhealth.com, elationhealth.com). Additionally, Elation has partnered with Seoul Medical Group to provide tailored EHR solutions for a nationwide primary care network serving over 100,000 patients, emphasizing its ecosystem relationships (elationhealth.com). The company also collaborates with Aledade, a leader in value-based care, supporting independent practices across the U.S. with data-driven insights and shared savings programs, and Suvida Healthcare, focusing on underserved seniors, to expand access and improve care outcomes (elationhealth.com, elationhealth.com). These partnerships demonstrate Elation’s strategic focus on integrating advanced technology solutions and expanding its ecosystem to support high-quality primary care delivery.

Events

Elation Health Event Participations

Elation Health actively participates in a variety of industry events, conferences, webinars, and community gatherings to showcase its healthcare solutions and engage with primary care professionals. Notably, they attended the JP Morgan Healthcare Conference 2025 in San Francisco from January 13-16, 2025, and CareOps Con 2025 in Nashville on January 23-24, 2025 (elationhealth.com). They also participated in the 2025 CAFP Foundation Annual Summit in Fort Collins, Colorado, from April 3-6, 2025, and the 2025 MSSNY House of Delegates in Tarrytown, NY, from April 4-6, 2025 (elationhealth.com). Additionally, they engaged with the healthcare community at the MGMA Private Practice Conference in Minneapolis from June 22-24, 2025, where they hosted booth #302 (elationhealth.com).

Beyond in-person events, Elation hosts and participates in webinars focused on innovative healthcare topics. For instance, they hosted a webinar titled "AI in Primary Care: A Behind-the-Scenes Look at Elation Health" on September 30, 2025, discussing AI development and its impact on primary care (elationhealth.com). They also organized a webinar on "How Primary Care Physicians are Innovating with AI", providing insights into AI integration in clinical practices (elationhealth.com). These events demonstrate Elation's commitment to thought leadership and community engagement in healthcare innovation.

Frequently Asked Questions

What does Elation Health's appointment of a new COO/President in late 2024 signal about where the company is headed operationally?

The hire of Nikolaus Trotta as COO and President in late 2024 — someone with nearly two decades of healthcare technology and finance experience — strongly suggests Elation is preparing for a more structured scaling phase, likely involving tighter operational discipline and potentially positioning for an exit or larger capital event. Coming roughly two years after the $50M Series D closed in July 2022, the move points to a leadership team being built for growth execution rather than early-stage experimentation. The simultaneous 2023 additions of a CFO, Chief People Officer, and Head of Customer reinforce that Elation is professionalizing its C-suite across all major functions.

Is Elation Health's $86M revenue run rate and $108.5M in total venture funding a healthy capital efficiency story, or does the funding gap raise questions?

At roughly $86M in annual revenue against $108.5M in total funding raised since 2010 — with the last round being a $50M Series D in July 2022 — Elation's capital efficiency looks reasonably strong for a SaaS healthcare platform, but the absence of a disclosed Series E after three-plus years raises questions about whether growth has plateaued or whether the company is managing toward profitability ahead of an exit. The gap between the last funding date and current revenue suggests the 2022 capital may still be fueling operations. Without a new round or disclosed path to profitability, corp-dev teams should probe burn rate and EBITDA margins carefully.

What does Elation Health's partnership with Aledade signal about its strategic push into value-based care?

The Aledade partnership signals that Elation is deliberately aligning its platform with the value-based care infrastructure that independent primary care practices increasingly depend on for financial sustainability. Aledade operates shared savings programs and provides data-driven insights to independent practices across the U.S., meaning Elation gains distribution into a high-value segment of its core market while adding a clinical outcomes layer that pure EHR competitors cannot easily replicate. Combined with the Suvida Healthcare partnership targeting underserved seniors, this pattern suggests Elation is building ecosystem stickiness beyond documentation, anchoring into the reimbursement and population health workflows that drive practice retention.

What does Elation Health's Best in KLAS win for Small Practice EHR/PM in two consecutive years — including 2026 — actually mean for its competitive moat against athenahealth and Practice Fusion?

Back-to-back Best in KLAS wins for Small Practice EHR/PM are a material competitive differentiator because KLAS ratings are driven by verified clinician feedback, making them a trusted proxy for renewal and referral behavior in the independent practice segment. Against athenahealth, which targets a similar size range but competes more on revenue cycle breadth, and Practice Fusion, which competes on price, the KLAS recognition gives Elation a credibility advantage in sales cycles where physicians seek peer validation. For a company serving over 32,000 clinicians without a large enterprise sales force, this kind of third-party endorsement functions as a low-cost demand generation asset.

What does Elation Health's AI product roadmap — specifically Note Assist and the September 2025 AI webinar — reveal about how it is responding to the ambient AI threat from players like Nabla or Suki?

Elation's positioning of Note Assist as the first AI-first technology integrated directly into a core EHR system, rather than as a bolt-on, suggests it is trying to defend against ambient AI point solutions by making AI a native layer of the clinical workflow rather than a separate subscription. The September 2025 webinar titled 'AI in Primary Care: A Behind-the-Scenes Look at Elation Health' indicates active market education and product evangelism, which typically accompanies a feature set that is live but still needs clinician adoption to build. The risk is that standalone ambient AI vendors can iterate faster; Elation's counter is that embedded AI reduces integration friction for its 32,000+ clinician base.

What does Elation Health's Zocdoc partnership tell us about where it sees patient acquisition and administrative burden as competitive battlegrounds?

The Zocdoc integration — enabling seamless online scheduling directly within Elation's platform — signals that Elation is competing on the full practice operations layer, not just clinical documentation. For independent primary care practices, front-end patient scheduling is a meaningful source of administrative drag and a driver of no-shows and revenue leakage, so reducing that friction increases practice ROI from the Elation platform. Strategically, it also positions Elation as a more complete operating system for independent practices, raising switching costs relative to EHR-only competitors and making it harder for practices to unbundle individual components.

What does Elation Health's hiring pattern — including a Chief Product Officer added in late 2023 and ongoing recruitment as of early 2026 — suggest about its near-term product roadmap priorities?

The addition of a Chief Product Officer in late 2023, combined with sustained hiring and no reported layoffs, suggests Elation is investing in structured product development rather than maintenance mode. For a company that claims to be the first EHR to integrate AI-first technology into its core system, having dedicated product leadership in place is a prerequisite for executing on that differentiation without fragmenting the clinical-first user experience. The ongoing recruitment as of early 2026 further implies the AI and billing automation roadmap is resource-constrained by talent, not capital, which is typical of engineering-led healthtech at this stage.

How should a corp-dev team interpret Elation Health's quote-based, non-public pricing model relative to its competitive positioning?

A quote-based pricing model at Elation's scale — serving 32,000+ clinicians with $86M in annual revenue — is a deliberate choice rather than an operational gap; it allows Elation to price-discriminate across practice sizes and network affiliations without public benchmarks that competitors can undercut. This creates friction for bottom-up competitive analysis but is consistent with a company defending average contract value as it moves upmarket toward larger independent networks and enterprise API customers. For acquisition due diligence, the lack of published tiers means revenue concentration, average ACV, and net revenue retention need to be extracted directly from financial disclosures rather than inferred from list pricing.

What does Elation Health's attendance at the JP Morgan Healthcare Conference 2025 signal about its M&A and investor relations posture?

Attending JP Morgan Healthcare — the premier annual forum for healthcare executive and investor deal-making — signals that Elation is actively maintaining visibility with strategic acquirers, late-stage investors, and potential partners at the highest level of the healthcare capital markets. For a Series D company with its last round closed in July 2022, presence at JPM in January 2025 is consistent with either exploring a Series E, preparing for an IPO narrative, or positioning for a strategic acquisition discussion. It is not a company that attends JPM passively; the conference is where term sheets and M&A conversations are initiated.

What does Elation Health's partnership with Seoul Medical Group — a nationwide network serving over 100,000 patients — reveal about its enterprise ambitions beyond the solo-practice segment?

The Seoul Medical Group deal, which involves providing tailored EHR solutions for a nationwide primary care network, is a meaningful signal that Elation is moving beyond its founding base of solo and small independent practices toward larger network contracts. Serving a 100,000-patient network requires configurability, multi-site coordination, and enterprise-grade support that the typical small-practice customer does not demand, indicating Elation's platform has matured to handle more complex deployments. This upmarket motion increases ACV potential but also puts Elation in more direct competition with athenahealth and, at the network level, potentially Epic-aligned regional systems.

What does the addition of Dr. Sara Pastoor as Head of Primary Care Advancement signal about Elation Health's clinical credibility strategy?

Hiring a physician into a named leadership role focused on primary care advancement — rather than purely a clinical informatics or medical director function — signals that Elation is investing in thought leadership and clinical advocacy as a go-to-market tool, not just product validation. In a market where physician skepticism of EHR vendors is high and KLAS ratings are driven by clinician trust, having a practicing physician in a visible leadership role supports both sales credibility and product development feedback loops. It also aligns with Elation's positioning at clinical-facing events like the CAFP Foundation Annual Summit and MSSNY House of Delegates, where physician-to-physician credibility matters more than vendor marketing.

What does Elation Health's event strategy — spanning MGMA Private Practice, CAFP, and MSSNY alongside JP Morgan — reveal about the tension between its SMB roots and enterprise ambitions?

Elation's event footprint spans two distinct audiences simultaneously: small and independent practice organizations like CAFP and MSSNY, where its 32,000-clinician base lives, and capital-markets forums like JP Morgan, where acquirers and institutional investors operate. This dual presence is consistent with a company that must sustain its core SMB customer base for revenue stability while building the investor and partner narrative needed for a liquidity event. The MGMA Private Practice Conference appearance — with a named booth — reinforces that the independent practice segment remains the commercial core, but the JPM attendance confirms corporate development is a parallel strategic priority.

Powered by ForesightIQ · Competitive intelligence from digital exhaust